Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine + triamcinolone infiltration for postoperative pain after Milligan-Morgan hemorrhoidectomy
2014-003043-35Phase 4Active
- Sponsor
- Hospital General de Vic
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine and triamcinolone acetonide in hemorrhoid, sponsored by Hospital General de Vic. Primary endpoint: Postoperative pain level during hospital stay. Started Dec 2014; status: active.
02
Drugs
bupivacainetriamcinolone acetonide
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on 2014-003043-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003043-35.